共 68 条
[51]
Pan-Canadian Oncology Drugs Review, TRAST KADC MBC FIN E
[54]
Cost-Effectiveness Analysis of Trastuzumab (Herceptin) in HER2-Overexpressed Metastatic Breast Cancer
[J].
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS,
2009, 32 (05)
:492-498
[55]
Use of the monoclonal antibody Anti-HER2 trastuzumab in the treatment of metastatic breast cancer - A cost-effectiveness analysis
[J].
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS,
2008, 31 (04)
:363-368